DENTSPLY Sirona Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
1.7%projected annual EPS growth
Analyst Coverage
16analysts covering
FY EPS (est.)
$1.50next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release (Estimated) | 5 Nov 2026 |
Monitoring Framework
Key Performance Indicators
DS Core Unique Accounts Annually37KTarget: Continued monthly user base expansion and global migration from Connect Case Center
Net Sales Guidance (FY 2026) Quarterly3.6BTarget: 3500000000 - 3600000000
Adjusted EPS Guidance (FY 2026) Quarterly1.5Target: 1.40 - 1.50
Annual Restructuring Cost Savings Quarterly120M
Watch Items
- Byte Business Wind-down and Drop-ship Model TransitionTrigger: Operational sales declines of 1% to 3% or inventory transition headwinds exceeding $30 millionAction: Monitor segment margins in Clinical Technology Solutions (CTS) and adjust commercial execution
- CFO Transition and Capital Allocation ExecutionTrigger: John Fortson's official assumption of the EVP and CFO role on July 20, 2026Action: Evaluate updates to the Return-to-Growth Action Plan, debt reduction velocity, and potential share repurchases
- DS Core Platform Adoption and Open Ecosystem IntegrationsTrigger: Slowing monthly active user growth or integration friction with third-party tools like exocadAction: Accelerate cloud-native feature rollouts (e.g., DS Core Diagnose) and expand free-tier lab accounts to secure digital dentistry workflows
Research as of 20 Jun 2026